Abstract:Background: Early recurrence is common for hepatocellular carcinoma (HCC) after surgical resection, being the leading cause of death. Traditionally, the COX proportional hazard (CPH) models based on linearity assumption have been used to predict early recurrence, but predictive performance is limited. Machine learning models offer a novel methodology and have several advantages over CPH models. Hence, the purpose of this study was to compare random survival forests (RSF) model with CPH models in prediction of early recurrence for HCC patients after curative resection.Methods: A total of 4,758 patients undergoing curative resection from two medical centers were included. Fifteen features including age, gender, etiology, platelet count, albumin, total bilirubin, AFP, tumor size, tumor number, microvascular invasion, macrovascular invasion, Edmondson-Steiner grade, tumor capsular, satellite nodules and liver cirrhosis were used to construct the RSF model in training cohort. Discrimination, calibration, clinical usefulness and overall performance were assessed and compared with other models.Results: Five hundred survival trees were used to generate the RFS model. The five highest Variable Importance (VIMP) were tumor size, macrovascular invasion, microvascular invasion, tumor number and AFP. In training, internal and external validation cohort, the C-index of RSF model were 0.725 [standard errors (SE) =0.005], 0.762 (SE =0.011) and 0.747 (SE =0.016), respectively; the Gönen & Heller's K of RSF model were 0.684 (SE =0.005), 0.711 (SE =0.008) and 0.697 (SE =0.014), respectively; the time-dependent AUC (2 years) of RSF model were 0.818 (SE =0.008), 0.823 (SE =0.014) and 0.785 (SE =0.025), respectively. The RSF model outperformed early recurrence after surgery for liver tumor (ERASL) model, Korean model, American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) stage, Barcelona Clinic Liver Cancer (BCLC) stage and Chinese stage. The RSF model is capable of stratifying patients into three different risk groups (low-risk, intermediate-risk, high-risk groups) in the training and two validation cohorts (all P<0.0001). A web-based prediction tool was built to facilitate clinical application (https://recurrenceprediction.shinyapps.io/surgery_predict/).Conclusions: The RSF model is a reliable tool to predict early recurrence for patients with HCC after curative resection because it exhibited superior performance compared with other models. This novel model will be helpful to guide postoperative follow-up and adjuvant therapy.

Preoperative identification of early extrahepatic recurrence after hepatectomy for colorectal liver metastases: A machine learning approach

Distribution and control of Chironomus riparius (Diptera: Chironomidae) in a polluted creek.

Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma

Machine learning models including preoperative and postoperative albumin-bilirubin score: short-term outcomes among patients with hepatocellular carcinoma

The influence of dead and fixed dead tissue in the living organism. 1. Problem statement and selection of a method of investigation.

Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma

[Increase in Parkinson symptoms caused by calcium antagonists].

A predictive model for early recurrence of colorectal-cancer liver metastases based on clinical parameters

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection

Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection

Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases

Impact of an artificial intelligence based model to predict non-transplantable recurrence among patients with hepatocellular carcinoma

Proton magnetic resonance studies of actinomycin D complexes with mixtures of nucleotides as models for the binding of the drug to DNA.

Machine learning-based multimodal prediction of prognosis in patients with resected intrahepatic cholangiocarcinoma.

A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases

Utilizing machine learning algorithms for predicting risk factors for bone metastasis from right-sided colon carcinoma after complete mesocolic excision: a 10-year retrospective multicenter study

Application of machine learning techniques in real-world research to predict the risk of liver metastasis in rectal cancer

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines

Personalized Prediction of Postoperative Complication and Survival Among Colorectal Liver Metastases Patients Receiving Simultaneous Resection Using Machine Learning Approaches: A Multi-center Study

Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study

Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment